Thomas McCourt

Thomas McCourt

Chief Executive OfficeratIronwood Pharmaceuticals· In proxies 2021–2025

Pay in FY2025-68% from the year before · Ironwood Pharmaceuticals stock -23.9% the same year

Thomas McCourt was paid $1.9M in FY2025 (Dec), down 68%. Ironwood Pharmaceuticals stock fell 23.9% that year.

Pay$100 in the stock at the end of FY20 → $32
Pay is from the Summary Compensation Table of each Ironwood Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Ironwood PharmaceuticalsPublic company · 5 yr
    • Chief Executive Officer2021 – Present · 5 yrStock in role -69%
  2. Pliant TherapeuticsPublic company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  3. Acceleron Pharma Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

Two people shown as one, or a wrong number?